While elevated SERPINA1 expression correlates with adverse clinical outcomes in diverse cancers [13], its functional role in HCC, particularly in the context of TACE resistance, remains largely unexplored. The gene discussed is SERPINA1; the disease is hepatocellular carcinoma.